Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil or oral S-1 improves the prognosis of patients with postoperative liver metastases from pancreatic cancer.

Tajima H, Kitagawa H, Tsukada T, Okamoto K, Nakanuma SI, Sakai S, Makino I, Furukawa H, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Itoh H, Fujita H, Takamura H, Ninomiya I, Fushida S, Fujimura T, Ohta T, Koda W, Minami T, Ryu Y, Sanada J, Gabata T, Matsui O, Sai Y.

Mol Clin Oncol. 2013 Sep;1(5):869-874. Epub 2013 Jul 23.

2.

Pilot study of hepatic arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for patients with postoperative liver metastases from pancreatic cancer.

Tajima H, Ohta T, Kitagawa H, Sakai S, Makino I, Hayashi H, Oyama K, Nakagawara H, Fujita H, Onishi I, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Koda W, Minami T, Ryu Y, Sanada J, Gabata T, Matsui O.

Exp Ther Med. 2011 Mar;2(2):265-269. Epub 2011 Jan 12.

3.

[Hepatic arterial infusion chemotherapy with gemcitabine for patients with postoperative liver metastases from pancreatic cancer].

Tajima H, Kitagawa H, Shoji M, Okamoto K, Nakanuma S, Sakai S, Kinoshita J, Makino I, Hayashi H, Nakamura K, Oyama K, Nakagawara H, Miyashita T, Takamura H, Ohta T, Minami T, Koda W, Sanada J, Gabata T, Sai Y.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1668-71. Japanese.

PMID:
24393883
4.

Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.

Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV Jr.

J Clin Oncol. 1997 Apr;15(4):1432-8.

PMID:
9193336
5.

Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.

Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.

Chin Med J (Engl). 2012 Oct;125(20):3640-5.

PMID:
23075717
6.

[A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion].

Iwauchi T, Amano R, Ohira G, Nakamoto K, Doi Y, Yamada N, Ohira M, Hirakawa K.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2373-5. Japanese.

PMID:
21224577
7.

Efficacy and safety of hepatic arterial infusion of fluorouracil with leucovorin as salvage treatment for refractory liver metastases from colorectal cancer.

Lee HJ, Lee YS, Lee KW, Kim SY, Yoon CJ, Shin DY, Lee YG, Choi SY, Kang SG, Kang SB, Kim JH.

Korean J Intern Med. 2011 Mar;26(1):82-8. doi: 10.3904/kjim.2011.26.1.82. Epub 2011 Mar 2.

8.

Multiple liver metastases of pancreatic solid pseudopapillary tumor treated with resection following chemotherapy and transcatheter arterial embolization: A case report.

Tajima H, Takamura H, Kitagawa H, Nakayama A, Shoji M, Watanabe T, Tsukada T, Nakanuma S, Okamoto K, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Ninomiya I, Fushida S, Fujimura T, Wakayama T, Iseki S, Ikeda H, Ohta T.

Oncol Lett. 2015 Apr;9(4):1733-1738. Epub 2015 Feb 16.

9.

Hepatic arterial infusion chemotherapy for post-operative liver metastases from pancreatic cancer in a patient with leukocytopenia: A case report.

Tajima H, Ohta T, Kitagawa H, Sakai S, Makino I, Hayashi H, Nakagawara H, Onishi I, Takamura H, Ninomiya I, Fushida S, Tani T, Fujimura T, Kayahara M, Koda W, Minami T, Ryu Y, Sanada J, Matsui O.

Exp Ther Med. 2010 Nov;1(6):987-990. Epub 2010 Sep 29.

10.

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.

Tsimberidou AM, Fu S, Ng C, Lim JA, Wen S, Hong D, Wheler J, Bedikian AY, Eng C, Wallace M, Camacho LH, Kurzrock R.

Cancer. 2010 Sep 1;116(17):4086-94. doi: 10.1002/cncr.25277.

11.

Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.

Link KH, Pillasch J, Formentini A, Sunelaitis E, Leder G, Safi F, Kornmann M, Beger HG.

Eur J Surg Oncol. 1999 Aug;25(4):381-8.

PMID:
10419708
12.

Basic research supported developments of chemotherapy in nonresectable isolated colorectal liver metastases to a protocol of hepatic artery infusion using mitoxantrone, 5-FU + folinic acid and mitomycin C.

Link KH, Kornmann M, Leder G, Pillasch AF, Sunelaitis E, Schatz M, Pressmar J, Beger HG.

Gan To Kagaku Ryoho. 1999 Feb;26(3):269-81. Review.

PMID:
10065089
14.

Weekly hepatic arterial infusion of 5-fluorouracil and subsequent systemic chemotherapy for liver metastases from colorectal cancer.

Hosokawa A, Yamada Y, Shimada Y, Muro K, Matsumura Y, Fujita S, Akasu T, Moriya Y, Shirao K.

Jpn J Clin Oncol. 2003 Mar;33(3):132-5.

PMID:
12672790
15.
16.

Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.

Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1419-22.

PMID:
18795703
17.
18.

Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.

Kozuch P, Grossbard ML, Barzdins A, Araneo M, Robin A, Frager D, Homel P, Marino J, DeGregorio P, Bruckner HW.

Oncologist. 2001;6(6):488-95.

19.

5-fluorouracil intra-arterial infusion combined with systemic gemcitabine for unresectable pancreatic cancer.

Takamori H, Kanemitsu K, Tsuji T, Tanaka H, Chikamoto A, Nakahara O, Hiraoka T, Ikeda O, Kudo K, Imuta M, Yamashita Y.

Pancreas. 2005 Apr;30(3):223-6.

PMID:
15782098
20.

Combined systemic chronotherapy and hepatic artery infusion for the treatment of metastatic colorectal cancer confined to the liver.

Shimonov M, Hayat H, Chaitchik S, Brener J, Schachter P, Czerniak A.

Chemotherapy. 2005 May;51(2-3):111-5. Epub 2005 May 11.

PMID:
15886466

Supplemental Content

Support Center